Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Relapsed Small Cell Lung Cancer · Recurrent Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto, California, United States
Contact: Study coordinator (Millie Das, MD) · Millie.Das@va.gov · 650-493-5000
Contact: Study coordinator (Niko Del Mar, RA) · niko.delmar@va.gov · 6504935000
Jesse Brown VA Medical Center, Chicago, IL, Chicago, Illinois, United States
Contact: Study coordinator (Larry Feldman, MD) · lawrence.feldman@va.gov · 312-569-5385
Contact: Study coordinator (Alicia Hulbert, MD) · alicia.hulbert@va.gov · 3124138878
Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis, Indiana, United States
Contact: Study coordinator (Shadia Jalal, MD) · Shadia.Jalal@va.gov · 317-274-5500
Contact: Study coordinator (Aleksandra Radovanovich, RN) · aleksandra.radovanovich@va.gov · (317) 988-3338
Contact: Principal Investigator (Shadia Jalal, MD)
Robley Rex VA Medical Center, Louisville, KY, Louisville, Kentucky, United States
Contact: Study coordinator (Fred Hendler, MD) · Fred.Hendler@va.gov · 502-287-4000
Contact: Study coordinator (Denise Zellars, MHA) · Denise.Zellars@va.gov · 5022875222
VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan, United States
Contact: Study coordinator (Nithya Ramnath,, MD) · nithya.ramnath@va.gov · 734-845-5800
Contact: Study coordinator (Kelsey Bollin, BSN) · Kelsey.Bollin@va.gov · (734) 8453966
Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis, Minnesota, United States
Contact: Study coordinator (Mark Klein, MD) · Mark.Klein2@va.gov · 612-467-4682
Contact: Study coordinator (Jasmeen Chauhan, BA) · Jasmeen.Chauhan@va.gov · 6124674682
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha, Nebraska, United States
Contact: Study coordinator (Apar Ganti, MD) · aparkishor.ganti@va.gov · 402-346-8800
Contact: Study coordinator (Anna Kellogg, MS) · anna.kellogg@va.gov · 4029954143
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC, Salisbury, North Carolina, United States
Contact: Study coordinator (Jimmy Ruiz, MD) · Jimmy.Ruiz@va.gov · 704-638-9000
Contact: Study coordinator (Travis Gallimore, RC) · Travis.Gallimore@va.gov · (704) 6389000
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Kyle Robinson, MD) · Kyle.Robinson2@va.gov · 215-823-5800
Contact: Study coordinator (Kelly Puchalski, BSN) · Kelly.Puchalski@va.gov · 2158235800
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (James Herman, MD) · James.Herman@va.gov · 412-360-3909
Contact: Study coordinator (Cheryl Dutka, RA) · Cheryl.Dutka@va.gov · 4123602372
Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States
Contact: Study coordinator (Daniel Shin, MD) · Daniel.Shin@va.gov · 310-478-3711

Study leads

Shadia Jalal, MD
Principal Investigator
Richard L. Roudebush VA Medical Center, Indianapolis, IN

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer

Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1

Boston, United States · Nashville, United States

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE3

Springdale, United States · Fullerton, United States

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Small Cell Lung Cancer · Advanced Solid Malignant Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Encinitas, United States · Fullerton, United States

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States